Showing results (191-200 of 299) with videos related to
Sort By:
Pageof 30
Cancer Chemotherapy and Pharmacology|November 8, 2011
The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancerHeather A Wakelee, Chris H Takimoto, Arturo Lopez-Anaya, et al.JCO Precision Oncology|February 9, 2022
EGFR Genotyping of Matched Urine, Plasma, and Tumor Tissue in Patients With Non-Small-Cell Lung Cancer Treated With Rociletinib, an EGFR Tyrosine Kinase InhibitorJonathan W Goldman, Chris Karlovich, Lecia V Sequist, et al.Nature Cancer|September 10, 2021
Circulating Tumor DNA Dynamics Predict Benefit from Consolidation Immunotherapy in Locally Advanced Non-Small Cell Lung CancerEverett J Moding, Yufei Liu, Barzin Y Nabet, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 27, 2010
Cetuximab monotherapy in patients with advanced non-small cell lung cancer after prior epidermal growth factor receptor tyrosine kinase inhibitor therapyJoel W Neal, Rebecca S Heist, Panos Fidias, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 21, 2021
Pharmacovigilance Analysis of Cardiac Toxicities Associated With Targeted Therapies for Metastatic NSCLCSarah Waliany, Han Zhu, Heather Wakelee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2007
Lung cancer incidence in never smokersHeather A Wakelee, Ellen T Chang, Scarlett L Gomez, et al.Clinical Lung Cancer|April 15, 2018
Update on International Cooperative Groups Studies in Thoracic Malignancies: The Emergence of ImmunotherapyNavika D Shukla, Ameen A Salahudeen, Gregory A Taylor, et al.Lung Cancer (Amsterdam, Netherlands)|April 19, 2023
Comparative effectiveness of mobocertinib and standard of care in patients with NSCLC with EGFR exon 20 insertion mutations: An indirect comparisonSai-Hong I Ou, Huamao M Lin, Jin-Liern Hong, et al.Clinical Lung Cancer|May 16, 2018
Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung CancerAlexander L Chin, Kiran A Kumar, Haiwei H Guo, et al.International Journal of Radiation Oncology, Biology, Physics|October 2, 2024
A Phase 2 Single-Arm Trial of High-Dose Precision Targeted Radiation Therapy Added to Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerMichael F Gensheimer, Nikhil V Kotha, Lucas K Vitzthum, et al.Pageof 30